|
|||||
|
|
| 醒脑静口服给药栀子苷在Beagle犬体内的药代动力学研究 | |
| 引用本文： | 田秀峰,李鹏跃,王宏洁,边宝林,杜守颖,杨健. 醒脑静口服给药栀子苷在Beagle犬体内的药代动力学研究[J]. 中国中药杂志, 2012, 37(16): 2461-2464 |
| 作者姓名： | 田秀峰 李鹏跃 王宏洁 边宝林 杜守颖 杨健 |
| 作者单位： | 1. 北京中医药大学,北京100102;炎黄东方(北京)健康科技有限公司,北京100024 2. 中国中医科学院中药研究所,北京,100700 3. 北京中医药大学,北京,100102 |
| 基金项目： | 国家重大新药创制科技重大专项(2009ZX09502-008);国家自然科学基金面上项目(81073057);教育部博士点基金项目(20090013110007);北京中医药大学复方中药制药创新团队(2011-CXTD-13) |
| 摘 要： | 目的:建立Beagle犬血浆中栀子苷的高效液相色谱分析方法,研究醒脑静口服给药后栀子苷的药代动力学特征及生物利用度。方法:Beagle犬分别口服、注射给予醒脑静,采用HPLC测定Beagle犬血浆中栀子苷浓度,以Kinetica软件拟合,计算相关药动学参数。结果:Beagle犬血浆中栀子苷在1.24～158.88 mg.L-1线性关系良好,口服给药的主要药动学参数为Cmax(11.8±0.6)mg.L-1,Tmax(52.0±4.5)min,AUC(1 280.8±172.0)mg.min.L-1,MRT(118.7±25.4)min。注射给药的药动学参数为Cmax(107.4±6.3)mg.L-1,AUC(7 930.1±670.0)mg.min.L-1,MRT(92.4±5.1)min。生物利用度为(6.46±0.87)%。结论:该实验建立的Beagle犬血浆中栀子苷的HPLC分析方法,适用性良好,提取、方法回收率和日内、日间精密度均符合要求,室温及冻融条件下稳定性良好。醒脑静口服给药栀子苷的生物利用度较低。 |
| 关 键 词： | 醒脑静 栀子苷 药代动力学 生物利用度 |
| 收稿时间： | 2012-05-09 |
Pharmacokinetics and bioavailabilities of geniposide in Beagle dogs after oral administration Xingnaojing |
|
| TIAN Xiufeng,LI Pengyue,WANG Hongjie,BIAN Baolin,DU Shouying and YANG Jian. Pharmacokinetics and bioavailabilities of geniposide in Beagle dogs after oral administration Xingnaojing[J]. China Journal of Chinese Materia Medica, 2012, 37(16): 2461-2464 | |
| Authors: | TIAN Xiufeng LI Pengyue WANG Hongjie BIAN Baolin DU Shouying YANG Jian |
| Affiliation: | Beijing University of Chinese Medicine, Beijing 100102, China;Yanhuang Dongfang (Beijing) Healthcare Technology Co., Ltd., Beijing 100024, China;Institute of Chinese Materia Madica, China Academy of Chinese Medical Sciences, Beijing 100700, China;Institute of Chinese Materia Madica, China Academy of Chinese Medical Sciences, Beijing 100700, China;Institute of Chinese Materia Madica, China Academy of Chinese Medical Sciences, Beijing 100700, China;Beijing University of Chinese Medicine, Beijing 100102, China;Institute of Chinese Materia Madica, China Academy of Chinese Medical Sciences, Beijing 100700, China |
| Abstract: | Objective : To establish a method for determination of geniposide in Beagle dogs plasma by high performance liquid chromatography (HPLC), and study the pharmacokinetics and bioavailability of geniposide in Beagle dogs after oral administration Xingnaojing. Method : To determine the geniposide in Beagle dogs plasma by HPLC after oral administration or intravenous injection Xingnaojing, and the pharmacokinetic parameters were calculated by the software of Kinetica. Result : The good linearity range of geniposide was 1.24-158.88 mg·L-1. The main pharmacokinetic parameters after oral administration was as follows: Cmax(11.8±0.6) mg·L-1,Tmax(52.0±4.5) min,AUC(1 280.8±172.0) mg·min·L-1,MRT(118.7±25.4) min, and these parameters after intravenous injection was follows: Cmax(107.4±6.3) mg·L-1,AUC(7 930.1±670.0) mg·min·L-1,MRT(92.4±5.1) min. The bioavailability of geniposide in Beagle dogs after oral administration Xingnaojing was (6.46±0.87)%. Conclusion : The HPLC method had good applicability. The extract recovery, method recovery, intra-day precision and inter-day precision of the method were all met the requirements. The stability in conditions of room temperature and freeze-thaw cycle was good. The results indicated that the oral administration bioavailability of geniposide was in low degree. |
| Keywords: | Xingnaojing geniposide pharmacokinetics bioavailability |
| 本文献已被 CNKI 万方数据 等数据库收录！ | |